NCT05639075

Brief Summary

Analyse the peripheral vision after cataract surgery with a new IOL compared to a standard IOL

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

November 28, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 6, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

December 6, 2022

Status Verified

November 1, 2022

Enrollment Period

1 year

First QC Date

November 28, 2022

Last Update Submit

December 5, 2022

Conditions

Keywords

CataractIntraocular lens

Outcome Measures

Primary Outcomes (1)

  • Peripheral vision

    Peripheral vision will be assessed via gait analysis and will be compared between both eyes

    24 months

Secondary Outcomes (2)

  • Refraction

    24 months

  • Visual acuity

    24 months

Study Arms (1)

Gait analysis

EXPERIMENTAL

A gait analysis test will be performed in each patient after cataract surgery to test peripheral vision

Other: Peripheral vision

Interventions

A gait analysis test will be performed in each patient after cataract surgery to test peripheral vision

Gait analysis

Eligibility Criteria

Age21 Years - 105 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pseudophakic patients with an Art 40 IOL in one eye and the standard monofocal ICB00 IOL in the other eye. A larger series of patients was operated in this way at Hanusch hospital in 2021 and 2022 as the department has the strategy of implanting a new IOL that has come to market in only one eye and the standard monofocal IOL in the contralateral eye to reduce potential risks, even though the new IOL had a CE mark and was readily available on the market.
  • Surgery should have been at least 1 month prior to study recruitment
  • Age 21 or older
  • Visual acuity \> 0,8
  • Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
  • Able to walk without walking aids
  • Written informed consent prior to commencing study measurements.

You may not qualify if:

  • nystagmus or pathologies that might affect patient's fixation or physical handicaps that may decrease gait stability
  • any ophthalmic comorbidity that may compromise the visual function or might interfere with the experiments (e.g., macular degeneration, corneal scars, pupil abnormalities, glaucoma)
  • reduced contrast sensitivity, binocularity, and stereoscopic vision (e.g., amblyopia, strabismus)
  • limitation of age-equivalent gait performance because of neurological, cardio-respiratory or musculoskeletal functional deficits
  • pregnancy (pregnancy test will be performed in women of reproductive age)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vienna Institute for Research in Ocular Surgery

Vienna, 1140, Austria

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Oliver Findl, MD

    Vienna Institute for Research in Ocular Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 28, 2022

First Posted

December 6, 2022

Study Start

November 1, 2022

Primary Completion

November 1, 2023

Study Completion

November 1, 2024

Last Updated

December 6, 2022

Record last verified: 2022-11

Locations